Epidemiologic study of cystic fibrosis: Design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada

Pediatric Pulmonology

Volumn 28, Issue 4, 1999, Pages 231-241

  Morgan, Wayne J ^a,l   Butler, Steven M ^b   Johnson, Charles A ^b   Colin, Andrew A ^c   FitzSimmons, Stacey C ^d   Geller, David E ^e   Konstan, Michael W ^f   Light, Michael J ^g   Rabin, Harvey R ^h   Regelmann, Warren E ⁱ   Schidlow, Daniel V ^j   Stokes, Dennis C ^k   Wohl, Mary Ellen B ^c   Kaplowitz, Haley ^b   Wyatt, Matthew M ^b   Stryker, Scott ^b  

^a UNIVERSITY OF ARIZONA   (United States)

^b GENENTECH INC   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d CYSTIC FIBROSIS FOUNDATION   (United States)

^e NEMOURS CHILDREN S HOSPITAL   (United States)

^f CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^h UNIVERSITY OF CALGARY   (Canada)

ⁱ UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^j DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^k VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^l UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I;

ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; CHILD; CYSTIC FIBROSIS; DEMOGRAPHY; FEMALE; FORCED EXPIRATORY VOLUME; GROWTH DISORDER; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MICROBIOLOGY; PATIENT SELECTION; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; UNITED STATES;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CANADA; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE; UNITED STATES;

EID: 13044254788     PISSN: 87556863     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-0496(199910)28:4<231::AID-PPUL1>3.0.CO;2-2     Document Type: Article

References (21)

1. FitzSimmons SC The changing epidemiology of cystic fibrosis. J Pediatr 1993;122:1-9.
2. Kosorok MR, Wei WH, Farrell PM. The incidence of cystic fibrosis. Stat Med 1996;15:449-462.
3. Riordan JR. The cystic fibrosis transmembrane conductance regulator. Annu Rev Physiol 1993;55:609-630.
4. Collins FS. Cystic fibrosis: molecular biology and therapeutic implications. Science 1992;256:774-779.
5. Welsh MJ, Tsui L-C, Boat TF, Beaudet AL. Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease, 7th edition, volume 3. New York: McGraw-Hill; 1995. p 3799-3876.
6. Davis PB, Drumm M, Konstan MW. Cystic fibrosis: state of the art. Am J Respir Crit Care Med 1996;154:1229-1256.
7. Konstan MW, Berger M. Infection and inflammation of the lung in cystic fibrosis. Lung Biol Health Dis 1993;64:219-276.
8. Littlewood JM. Cystic fibrosis: gastrointestinal complications. Br Med Bull 1992;48:847-859.
9. Quinton PM, Reddy MM. The sweat gland. Lung Biol Health Dis 1993;64:137-159.
10. Cystic Fibrosis Foundation Committee. CFF guidelines for patient services, evaluation, and monitoring in CF centers. Am J Dis Child 1990;144:1311-1312.
11. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. J Pediatr 1998;132:589-595.
12. Ramsey BW. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med 1996;335:179-188.
13. Konstan MW, Butler SM, Schidlow DV, Morgan WJ, Julius JR, Johnson CA. Patterns of medical practice in cystic fibrosis. Part 1. Evaluation and monitoring of health status of patients. Pediatr Pulmonol 1999;28:242-247.
14. Konstan MW, Butler SM, Schidlow DV, Morgan WJ, Julius JR, Johnson CA. Patterns of medical practice in cystic fibrosis: Part 2. Use of therapies. Pediatr Pulmonol 1999;28:248-254.
15. American Thoracic Society. Standardization of spirometry: 1987 update. Am Rev Respir Dis 1987;136:1285-1298.
16. Blethen SL, Breen TJ, Attie KM. Overview of the National Cooperative Growth Study substudy of serial growth hormone measurements. J Pediatr 1996;128:38-41.
17. Brasfield D, Hicks G, Soong S, Peters J, Tiller R. Evaluation of scoring system of the chest radiograph in cystic fibrosis: a collaborative study. AJR 1980;134:1195-1198.
18. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983;127:725-734.
19. Kingdom TT, Lee KC, FitzSimmons SC, Cropp GJ. Clinical characteristics and genotype analysis of patients with cystic fibrosis and nasal polyps requiring surgery. Arch Otolaryngol Head Neck Surg 1996;122:1209-1213.
20. Frieman JP, FitzSimmons SC. Colonic strictures in patients with cystic fibrosis: results of a survey of 114 cystic fibrosis care centers in the United States. J Pediatr Gastroenterol Nutr 1996; 22:153-156.
21. Neglia JP, FitzSimmons SC, Maisonneuve P, Schoni MH, Schöni-Affolter F, Corey M, Lowenfels AB. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med 1995;332:494-499.